Bowel cancer breakthrough as new drug could triple survival chance in patients
Pembrolizumab boosts the immune system’s ability to attack cancer. A study found that 59% of patients’ tumours shrank so much that there were no signs of disease when the affected section of their bowel was removed
Source: mirror.co.uk